Stevanato Group S.p.A. (STVN)
| Bid | 20.7 |
| Market Cap | 5.94B |
| Revenue (ttm) | 1.11B |
| Net Income (ttm) | 117.78M |
| EPS (ttm) | 0.49 |
| PE Ratio (ttm) | 44.41 |
| Forward PE | 30.61 |
| Analyst | Hold |
| Ask | 22.99 |
| Volume | 258,490 |
| Avg. Volume (20D) | 357,304 |
| Open | 22.03 |
| Previous Close | 21.81 |
| Day's Range | 21.56 - 22.15 |
| 52-Week Range | 16.56 - 28.77 |
| Beta | 0.52 |
About STVN
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, I...
Analyst Forecast
According to 6 analyst ratings, the average rating for STVN stock is "Hold." The 12-month stock price forecast is $24.75, which is an increase of 13.74% from the latest price.
Stock Forecasts
20 hours ago · businesswire.com
Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,...
